Clariant AG (CLZNY)

Featured in Bullish Trend Stocks

Clariant AG is a Swiss specialty chemicals company whose common stock is represented in the U.S. through this ADR listing on OTC Markets. The company develops, manufactures, distributes, and sells specialty chemical products across Switzerland, Europe, the Middle East, Africa, the United States, and Asia Pacific. Its operations are organized into three segments: Care Chemicals, Catalysts, and Adsorbents & Additives. Care Chemicals covers applications used in personal and home care, crop solutions, industrial uses, base chemicals, oil services, and mining. Catalysts focuses on propylene and ethylene, syngas and fuels, and specialty applications. Adsorbents & Additives supplies solutions used in coatings, adhesives, polymers, agriculture, food, electronics, automotive, building and construction, aviation, oil, and mining. Founded in 1886, Clariant is headquartered in Muttenz, Switzerland.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-CLZN.Y	$15.26	21.2% Upside	Undervalued	Not available	Not available	Good	3.7%	November 3, 2026	1.7x	0.9x	4.285 B	5.826 B	36.7%	59.2%	8.0	-444.7%	-1,103.5%

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Materials

Index Membership

Strong Buy

Valuation Snapshot

Fair Value

$15.26

Valuation Gap

21.2% Upside

Quality & Risk

Financial Health

Good

Piotroski Score

699.2 M

Altman Z-Score

8.0

Upcoming Events

Next Earnings Date

November 3, 2026

Days to Earnings

Strong Buy

Valuation • Fair Value

Clariant AG (OTC-CLZN.Y) Fair Value by Valuation Model

Review the available estimates for Clariant AG (OTC-CLZN.Y), including Ben Graham Formula Value.

Primary Valuation Read

Fair Value

$15.26

Estimated upside of 21.2% versus the current market price.

Ben Graham Formula Value

Classic Ben Graham valuation formula reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 2 available valuation references for Clariant AG (OTC-CLZN.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Clariant AG (OTC-CLZN.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

Neutral

Current operating scale indicator.

Revenue Forecast

Buy

Forward revenue estimate.

EBITDA

Chemicals

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Clariant AG (OTC-CLZN.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Clariant AG (OTC-CLZN.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

699.2 M

Relatively strong quality score.

Beneish M-Score

823 M

Higher caution zone on this screen.

Altman Z-Score

8.0

Relatively strong balance-sheet zone.

FCF / Net Income

-1,103.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Clariant AG (OTC-CLZN.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Clariant AG (OTC-CLZN.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 3, 2026

Days to Earnings

Strong Buy

Dividend Yield

3.7%

Current income yield reference.

Payout Ratio

-444.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Clariant AG (OTC-CLZN.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Analyst Outlook

Analyst Consensus for Clariant AG (OTC-CLZN.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Analyst Consensus for Clariant AG (OTC-CLZN.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy

Consolidated analyst recommendation mix

Hold

Based on the available recommendation mix, Clariant AG (OTC-CLZN.Y) has a Hold consensus, with 0 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 0

Hold 5

Sell 0

FAQ • Fast Investor Answers

Clariant AG (OTC-CLZN.Y) Stock FAQ

Data-supported answers about Clariant AG (OTC-CLZN.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

$15.26

Estimated upside 21.2%

Valuation Rating

Undervalued

Estimated upside of 21.2%

Financial Health

Good

Current financial-health read

The current fair value estimate for Clariant AG (OTC-CLZN.Y) is $15.26. This implies an estimated upside of 21.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 21.2% versus the current market price.

The current financial health read for Clariant AG (OTC-CLZN.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Clariant AG (OTC-CLZN.Y) is November 3, 2026.

Based on the current data, dividend yield is 3.7%.

The current market capitalization listed for Clariant AG is 4.285 B.

The current enterprise value listed for Clariant AG is 5.826 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Clariant AG is OTC-CLZN.Y, and the stock is listed on OTC Markets.

Clariant AG (OTC-CLZN.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Clariant AG is 36.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Clariant AG is 59.2%. Free float helps investors understand how much of the share base is available for public trading.